Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 11 Aug 2023 08:05 CEST |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | - |
| 11 Aug 2023 08:00 CEST |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 19 Jul 2019 12:21 CEST |
OXURION | Oxurion NV Reports Positive Topline Phase 1 Results with THR-149, a novel, potent plasma kallikrein inhibitor for the treatment of DME | Biotechnology | Products and services |